For: | Qureshi K, Bonder A. Thrombopoietin-receptor agonists in perioperative treatment of patients with chronic liver disease. World J Meta-Anal 2020; 8(3): 220-232 [DOI: 10.13105/wjma.v8.i3.220] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i3/220.htm |
Number | Citing Articles |
1 |
Dragos-Viorel Scripcariu, Bogdan Huzum, Cornelia Mircea, Dragos-Florin Tesoi, Oana-Viola Badulescu. Systemic Impact of Platelet Activation in Abdominal Surgery: From Oxidative and Inflammatory Pathways to Postoperative Complications. International Journal of Molecular Sciences 2025; 26(15): 7150 doi: 10.3390/ijms26157150
|
2 |
Robert Flisiak, Krasimir Antonov, Pavel Drastich, Peter Jarcuska, Marina Maevskaya, Mihály Makara, Željko Puljiz, Borut Štabuc, Anca Trifan. Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. Journal of Clinical Medicine 2021; 10(22): 5419 doi: 10.3390/jcm10225419
|
3 |
I Dewa Nyoman Wibawa, I Ketut Mariadi, Gde Somayana, Dwijo Sindhughosa. Efficacy and Safety of Thrombopoietin Receptor Agonist (TPO-RA) in Patients with Chronic Liver Disease: A Systematic Review and Meta-Analysis. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-143200
|